Decibel Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Decibel Therapeutics, Inc. | DBTX - NASDAQ |
$16.00-$18.00 | $18.00 | $21.20 | 7.062 million | 2/12/2021 |
| Citigroup, SVB Leerink, BMO Capital Markets, Barclays | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-22 Terms Added 2021-02-08 | ||||||
Decibel Therapeutics, Inc. Quote & Chart - Click for current quote - DBTX
IPO Boutique aggregates information on public companies and private companies, such as "DBTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Decibel Therapeutics, Inc. (adapted from Decibel Therapeutics, Inc. prospectus):
They are a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders, one of the largest areas of unmet need in medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders, one of the largest areas of unmet need in medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "DBTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.